Report
Geoffroy Michalet

Tikehau Capital : Cession d’un bloc de 3.5m d’actions Eurazeo – entrée en liste conviction

>Allègement significatif du bilan dans Eurazeo - Tikehau a annoncé hier soir avoir cédé un bloc de 3.5m (4.5%) d’actions Eurazeo, pour un montant de 224 M€. pour rappel, Tikehau détenais environ 7.5m d’actions Eurazeo avant le placement, il lui en reste donc environ 4m d’actions (5.1%) soit environ 270 M€ au cours d’hier soir. Le sens de l’histoire voudrait que Tikehau s’allège davantage dans les trimestres à venir en fonction du cours d’Eurazeo et des opportunités de...
Underlying
Tikehau Capital SCA

Tikehau Capital SCA Formerly known as Tikehau Capital SCS. Tikehau Capital SCA is a France-based asset management and investment company. The Company invests in various asset classes, including Private Debt, which comprises debt financing transactions, such as senior debt, unitranche and mezzanine, as well as collateralized loan obligations; Real Estate, which focuses on commercial property and seeks sale and lease-back transactions in which the Company's vehicles act as purchaser; Private Equity, which encompasses investments in the equity capital of listed and non-listed companies, and Liquid Strategies, which encompasses investments in bonds, investment grade securities and the management of open-ended funds. The Company operates either through direct equity investments or through its asset management subsidiary, Tikehau IM, on behalf of institutional and private investors. The Company has offices in Paris, London, Brussels, New York and Singapore, among others.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Geoffroy Michalet

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch